Skip to main content

Jamjoom Pharma

جمجوم فارما
4015 Main Market Shariah Compliant Hold
119.20 SAR
+2.10 (+1.79%)
Market Cap 8.34B SAR
Volume 51.46K shares
P/E Ratio 17.40
Dividend Yield 3.59%
52-Week Range Pharma, Biotech & Life Sciences
112.20
161.07
Last Updated: November 17, 2026 Confidence: 50%

Technical Analysis & Signals

Hold
Confidence 50%

Jamjoom Pharma closed at SAR 119.2, up 1.79%. RSI at 48.5 in neutral zone. Current signal: Hold.

Support 111.31 SAR
Resistance 143.50 SAR
Short-term (1-2 weeks) 122.78 SAR
Medium-term (1-3 months) 128.74 SAR
Risk Score
5/10 Medium
Technical Analysis

Jamjoom Pharma closed at SAR 119.2, below the 50-day SMA (125.17 SAR). RSI at 48.5 (neutral). MACD shows bullish momentum with histogram at 0.6986. Bollinger range: 111.31 – 124.37 SAR.

Support & Resistance Levels

Key support at SAR 111.31. Resistance at SAR 143.5. A break below support could push the stock toward SAR 107.97, while a breakout above resistance opens the path to SAR 147.81.

Volume Analysis

Session volume 51,458 shares is below the 30-day average (52,481 shares). Lower volume may indicate a wait-and-see market stance.

Fundamental Factors

P/E ratio at 17.4x. Dividend yield around 2.9%, attractive for income investors. Market cap SAR 8,344,000,000.0.

Risk Factors

Technical indicators sit in neutral territory (RSI 48, debt-to-equity 0.0203).

Recommendation

Based on current technical and fundamental data for Jamjoom Pharma. Monitor support at SAR 111.31 and resistance at SAR 143.5 for entry and exit points.

Analyzed: November 17, 2026, 6:05 PM Rule-based analysis

Financial Fundamentals

Market Cap 8.34B
P/E Ratio 17.40
P/B Ratio 4.60
EPS 6.87
Dividend Yield 3.59%
Dividend/Share 4.20
ROE 27.80%
Debt/Equity 0.02
Free Float 34.31%
Shares Outstanding 70.00M

Price Data

52-Week High 161.07
52-Week Low 112.20
3-Month High 143.50
3-Month Low 112.20
Open 116.60
Day's High 119.50
Day's Low 115.30
Previous Close 117.10

Price Chart - Jamjoom Pharma

4015

Technical Analysis

Current Price: 119.20 SAR
Overall Technical Signal Bullish Signal
4 Bullish 2 Neutral 3 Bearish

Moving Averages

SMA 20 117.84 SAR
Bullish
SMA 50 125.17 SAR
Bearish
SMA 200 139.08 SAR
Bearish
EMA 12 116.91 SAR
Bullish
EMA 26 119.53 SAR
Bearish
Current Price 119.20 SAR — Price above average = Bullish

Momentum Indicators

RSI 14
48.50 Neutral
Oversold (<30) Neutral Overbought (>70)
MACD Bullish
MACD -2.614
Signal -3.313
Histogram +0.699

Bollinger Bands

Within Band
Upper Band 124.37 SAR
Middle Band 117.84 SAR
Lower Band 111.31 SAR
Price position within band
Lower Band Upper Band
Average True Range (ATR) 2.76 SAR

Trend Strength (ADX)

Moderate Trend
22.0
Weak (<20) Moderate Strong (>40)
+DI (Bullish) 20.20
-DI (Bearish) 19.80
Dominant Trend: Bullish
On-Balance Volume (OBV) -3.15M shares

Financial Summary

Jamjoom Pharma

Valuation

Market Cap
8.34B
P/E Ratio
17.40
P/B Ratio
4.60
EPS (Earnings/Share)
6.87

Profitability

Revenue
1.59B
Net Income
484.13M
Return on Equity (ROE)
+27.80%
Shares Outstanding
70.00M

Balance Sheet

Total Assets
2.05B
Total Debt
37.15M
Debt/Equity
0.02
Free Float %
+34.3%

Dividends & Margins

Dividend Yield
+3.59%
Dividend/Share
4.20
Book Value
25.91

Financial data extracted from published quarterly reports. All values in SAR unless otherwise stated.

Historical Financial Data

5 years
Year RevenueNet IncomeTotal AssetsTotal DebtEPS
2025
1.50B +13.8%
463.80M +30.1%
2.05B +15.5%
16.43M +684.5%
6.63 +30.3%
2024
1.32B +19.8%
356.52M +21.9%
1.77B +7.1%
2.09M -12.8%
5.09 +21.8%
2023
1.10B +20.1%
292.40M +70.7%
1.65B +17.5%
2.40M -8.9%
4.18 +70.6%
2022
916.67M
171.31M
1.41B
2.64M
2.45
2021 — — — — —

Historical data sourced from Yahoo Finance and may differ from official audited financial reports.

Price Forecast

Hold
Hold
Confidence
50%
Price Range
Resistance 143.50 +20.39%
Medium Target 128.74 +8.00%
Short Target 122.78 +3.00%
Current Price 119.20
Support 111.31 -6.62%
Short-term Target 1-3 months
122.78 +3.00%
Medium-term Target 3-6 months
128.74 +8.00%
Upside +8.0%
Downside -6.6%
Risk/Reward Ratio Acceptable
1.21 : 1

These forecasts are based on technical analysis and AI and do not constitute investment advice. Past performance does not guarantee future results.

News & Events

No news currently available for Jamjoom Pharma

Sector Comparison

Pharma, Biotech & Life Sciences

Dividend History

Jamjoom Pharma
Annual Total per Share
2026
4.20
3.5%
2025
3.46
2.9%
2024
3.10
2.6%
2023
1.00
0.8%
Amount per share Yield %
Recent Payments
August 2026 2.20
March 2026 2.00
July 2025 2.00
March 2025 1.46
August 2024 1.60
June 2024 1.50
August 2023 1.00

Dividend data from Tadawul records. All amounts in SAR. Estimated yield calculated based on year-end price.

Ownership Structure

Locked Ownership65.69%
Free Float34.31%

Data source: Yahoo FinanceLast updated: 2026-11-17

Risk Assessment

Medium
Low 3
Medium 2
High 0

Risk Factors

✓
Low Volatility Low

Average True Range 2.3% of stock price

✓
Good Liquidity Low

Trading volume near or above average

!
Fair Valuation Medium

P/E ratio 17.4

✓
Low Debt Low

Debt-to-equity ratio 0.02

!
Moderate Trend Medium

ADX indicator at 22

Medium

Moderate risk factors with some sector pressures

Confidence Level 50%
Analysis Signal Hold

This assessment is automated based on quantitative data and does not constitute investment advice. Please consult a licensed financial advisor before making investment decisions.

FAQ

6 question
1 What is Jamjoom Pharma stock price today?

Jamjoom Pharma (4015) stock price today is 119.20 SAR, gaining by +1.79% compared to the previous session close. The 52-week price range is between 112.20 SAR and 161.07 SAR.

2 What is Jamjoom Pharma stock valuation?

The automated analysis signal for Jamjoom Pharma is "Hold" with 50% confidence. The P/E ratio is 17.4. The P/B ratio is 4.60.

3 Is Jamjoom Pharma Shariah-compliant?

Yes, Jamjoom Pharma (4015) is Shariah-compliant according to the latest lists approved by relevant Shariah authorities.

4 What are Jamjoom Pharma dividend distributions?

Jamjoom Pharma has a dividend yield of 3.59%, with an estimated annual dividend of 4.20 SAR per share.

5 What is Jamjoom Pharma weekly performance?

Jamjoom Pharma performance over different time periods: weekly change +5.67%, monthly -4.26%, and year-to-date -14.59%. The stock is currently trading with a volume of 51,458 shares.

6 What is the target level for Jamjoom Pharma?

According to automated analysis for Jamjoom Pharma: Short-term target (1-2 weeks): 122.78 SAR. Medium-term target (1-3 months): 128.74 SAR. Support level: 111.31 SAR. Resistance level: 143.50 SAR. Note: These are automated analytical levels and do not constitute investment advice.

Disclaimer

The information provided on this page is for educational and analytical purposes only and does not constitute investment advice or a recommendation to buy or sell. Past performance does not guarantee future results. All investments involve risk including loss of capital. Please consult a licensed financial advisor before making any investment decisions.

Automated analysis relies on historical data and technical indicators and may not reflect future market conditions.